These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29632234)

  • 21. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
    Spyropoulos AC; Ageno W; Albers GW; Elliott CG; Halperin JL; Hiatt WR; Maynard GA; Steg PG; Weitz JI; Suh E; Spiro TE; Barnathan ES; Raskob GE;
    N Engl J Med; 2018 Sep; 379(12):1118-1127. PubMed ID: 30145946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment.
    Schindewolf M; Weitz JI
    Thromb Haemost; 2020 Jan; 120(1):14-26. PubMed ID: 31858522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban versus Aspirin in Prevention of Venous Thromboembolism: A Meta-Analysis of 9 Randomized Controlled Trials comprising 7,656 Patients.
    Xie J; Jiang M; Lin Y; Deng H; Xie X; Li L
    Thromb Haemost; 2019 Sep; 119(9):1517-1526. PubMed ID: 31365943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose aspirin for preventing recurrent venous thromboembolism.
    Brighton TA; Eikelboom JW; Mann K; Mister R; Gallus A; Ockelford P; Gibbs H; Hague W; Xavier D; Diaz R; Kirby A; Simes J;
    N Engl J Med; 2012 Nov; 367(21):1979-87. PubMed ID: 23121403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study.
    Lim MS; Indran T; Cummins A; Bennett A; Wood E; Brown S; McQuilten Z; Tran H; Epi MC; Chan NC; Chunilal S
    Semin Thromb Hemost; 2019 Mar; 45(2):187-195. PubMed ID: 30566971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study.
    Søgaard M; Nielsen PB; Skjøth F; Kjaeldgaard JN; Larsen TB
    Cancer Med; 2019 Mar; 8(3):1044-1053. PubMed ID: 30767432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
    Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies.
    Khorana AA; Weitz JI
    Thromb Haemost; 2018 May; 118(S 01):S23-S33. PubMed ID: 29566417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term treatment of venous thromboembolism].
    Meyer G; Couturaud F
    Rev Prat; 2015 Feb; 65(2):208-13. PubMed ID: 25939225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
    Hess CN; Szarek M; Anand SS; Bauersachs RM; Patel MR; Debus ES; Nehler MR; Capell WH; Beckman JA; Piazza G; Henkin S; Bura-Rivière A; Lawall H; Roztocil K; Hsia J; Muehlhofer E; Berkowitz SD; Haskell LP; Bonaca MP
    JAMA Netw Open; 2022 Jun; 5(6):e2215580. PubMed ID: 35731517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin for preventing the recurrence of venous thromboembolism.
    Becattini C; Agnelli G; Schenone A; Eichinger S; Bucherini E; Silingardi M; Bianchi M; Moia M; Ageno W; Vandelli MR; Grandone E; Prandoni P;
    N Engl J Med; 2012 May; 366(21):1959-67. PubMed ID: 22621626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials.
    Weitz JI; Chan NC
    Thromb Haemost; 2019 May; 119(5):689-694. PubMed ID: 30808045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboprophylaxis by rivaroxaban, aspirin, both, or placebo after hospitalization for medical illness.
    Tomkowski WZ; Davidson BL
    Thromb Res; 2019 Aug; 180():62-63. PubMed ID: 31226663
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.
    Sobieraj DM; Coleman CI; Pasupuleti V; Deshpande A; Kaw R; Hernandez AV
    Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes.
    Gaertner S; Cordeanu EM; Nouri S; Faller AM; Frantz AS; Mirea C; Bilbault P; Ohlmann P; Le Ray I; Stephan D
    Int J Cardiol; 2017 Jan; 226():103-109. PubMed ID: 27806307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin and recurrent venous thromboembolism.
    Prandoni P; Noventa F; Milan M
    Phlebology; 2013 Mar; 28 Suppl 1():99-104. PubMed ID: 23482543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin versus rivaroxaban in postoperative bleeding after total knee arthroplasty: a retrospective case-matched study.
    Yuenyongviwat V; Tuntarattanapong P; Chuaychoosakoon C; Iemsaengchairat C; Iamthanaporn K; Hongnaparak T
    Eur J Orthop Surg Traumatol; 2019 May; 29(4):877-881. PubMed ID: 30627921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study.
    Sindet-Pedersen C; Staerk L; Pallisgaard JL; Gerds TA; Berger JS; Torp-Pedersen C; Gislason GH; Olesen JB
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):220-227. PubMed ID: 29945162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.
    Søgaard M; Nielsen PB; Skjøth F; Kjældgaard JN; Coleman CI; Larsen TB
    Am J Med; 2018 Jul; 131(7):787-794.e4. PubMed ID: 29476744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.